Mark A. Zorbas
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Co-authors
- Lynn C. Yeoman (5 shared papers)David L. Shelton (7 shared papers)Gary E. Gallick (3 shared papers)Stephanie Webber (7 shared papers)Susan I. Hurst (6 shared papers)Bhasker V. Shetty (3 shared papers)Matilde Olivé (2 shared papers)Bradley M. Kerr (2 shared papers)
- Journals
- Regulatory Toxicology and Pharmacology (3 papers)Human & Experimental Toxicology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Toxicological Sciences (2 papers)Neuroscience (1 paper)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Mark A. Zorbas
25 papers receiving 460 citations
Peers
Comparison fields: 5 of 75
- Virology 38
- Infectious Diseases 90
- Oncology 113
- Cellular and Molecular Neuroscience 57
- Cancer Research 42
Countries citing papers authored by Mark A. Zorbas
This map shows the geographic impact of Mark A. Zorbas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Zorbas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Zorbas more than expected).
Fields of papers citing papers by Mark A. Zorbas
This network shows the impact of papers produced by Mark A. Zorbas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Zorbas. The network helps show where Mark A. Zorbas may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Zorbas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 113 | |
| 2 | Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. | 1991 | 80 |
| 3 | 2016 | 48 | |
| 4 | Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034. | 2000 | 36 |
| 5 | Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene. | 1993 | 31 |
| 6 | 2017 | 28 | |
| 7 | 2010 | 26 | |
| 8 | 2014 | 19 | |
| 9 | 1993 | 13 | |
| 10 | 2005 | 13 | |
| 11 | 2014 | 13 | |
| 12 | 1993 | 11 | |
| 13 | Transferrin and insulin enhance human colon tumor cell growth by differentiation class specific mechanisms. | 1996 | 9 |
| 14 | 2018 | 9 | |
| 15 | 2013 | 8 | |
| 16 | 2016 | 5 | |
| 17 | 2003 | 3 | |
| 18 | 2003 | 3 | |
| 19 | 1989 | 2 | |
| 20 | 2004 | 2 |
About Mark A. Zorbas
Mark A. Zorbas is a scholar working on Oncology, Virology, Infectious Diseases, Cellular and Molecular Neuroscience and Physiology, having authored 25 papers that have together received 479 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (6 papers), HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers), Youth Education and Societal Dynamics (2 papers), Biochemical and Molecular Research (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). The work is most often cited by research in Virology (38 citations), Infectious Diseases (90 citations), Oncology (113 citations), Cellular and Molecular Neuroscience (57 citations) and Cancer Research (42 citations). Mark A. Zorbas has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Lynn C. Yeoman, David L. Shelton, Gary E. Gallick, Stephanie Webber, Susan I. Hurst, Bhasker V. Shetty, Matilde Olivé, Bradley M. Kerr, Mark T. Butt and Xinglin Wu. Their work appears in journals such as Regulatory Toxicology and Pharmacology, Human & Experimental Toxicology, Antimicrobial Agents and Chemotherapy, Toxicological Sciences and Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.